Cognitive Enhancement — Protocol Reference

In this stack — snapshot; tap through for the full molecule file

Provenance & evidence layers — of the combination, not the parts

RU-registered

Basis: real-world uptake & convention — not trial data

No approved clinical use

Basis required for a clinical-use tag: none found — absence shown, not hidden

Regulatory — read carefully

Basis: Russian state register (Semax, Selank) — public clinical use since the 1990s

Why this combination

Semax and Selank are Russian-registered neuropeptides with decades of public clinical use and moderate trial support. Dihexa is the outlier — potent preclinically, no human data. The pairing's free information is strong; the actionable depth is gated.

Members only · the actionable depth

See exactly how it's run

Doses, cycle structure and what to monitor are part of membership. The provenance, evidence and exposure above are always free.

Start 30 days free →

No card needed · cancel anytime

Cycle shape — how it's typically structured, not a schedule to follow

build up

Maintenance

hold / taper

Off

stop / reassess

Convention from community use, not a prescription. Specific timing is part of membership.

What's worth monitoring

With limited or no human safety data for this combination, there is no established marker set to monitor against — which is a reason for more caution, not less. Baseline bloods and a clinician conversation matter here. General information, not medical advice.